Using Propensity Scores Subclassification to Estimate Effects of Longitudinal Treatments

BACKGROUND: When using observational data to compare the effectiveness of medications, it is essential to account parsimoniously for patients' longitudinal characteristics that lead to changes in treatments over time. OBJECTIVES: We developed a method of estimating effects of longitudinal treatments that uses subclassification on a longitudinal propensity score to compare outcomes between a new drug (exenatide) and established drugs (insulin and oral medications) assuming knowledge of the variables influencing the treatment assignment. RESEARCH DESIGN/SUBJECTS: We assembled a retrospective cohort of patients with diabetes mellitus from among a population of employed persons and their dependents. METHODS: The data, from i3Innovus, includes claims for utilization of medications and inpatient and outpatient services. We estimated a model for the longitudinal propensity score process of receiving a medication of interest. We used our methods to estimate the effect of the new versus established drugs on total health care charges and hospitalization. RESULTS: We had data from 131,714 patients with diabetes filling prescriptions from June through December 2005. Within propensity score quintiles, the explanatory covariates were well-balanced. We estimated that the total health care charges per month that would have occurred if all patients had been continually on exenatide compared with if the same patients had been on insulin were minimally higher, with a mean monthly difference of $397 [95% confidence interval (CI), $218-$1054]. The odds of hospitalization were also comparable (relative odds, 1.02; 95% CI, 0.33-1.98). CONCLUSIONS: We used subclassification of a longitudinal propensity score for reducing the multidimensionality of observational data, including treatments changing over time. In our example, evaluating a new diabetes drug, there were no demonstrable differences in outcomes relative to existing therapies

Cohort study · Confidence interval · Diabetes mellitus · Environmental health · Exenatide · Logistic regression · Longitudinal study · Medical prescription · Observational study · Odds · Odds ratio · Population · Propensity score matching · Retrospective cohort study · Type 2 diabetes · Advanced Causal Inference Techniques · Emergency Medicine · Health Systems, Economic Evaluations, Quality of Life · Internal Medicine · Medication Adherence and Compliance · Medicine · Pharmacology

• An Introduction to Propensity Scores

  Open Access•Sarah J Beal, Kevin A Kupzyk et al.•The Journal of Early Adolescence•2013

  Incluir item

• Emerging Methods in Comparative Effectiveness and Safety

  Kathleen N Lohr•Medical Care•2007

  Incluir item

• Marginal Structural Models and Causal Inference in Epidemiology

  James M Robins, Miguel A Hernán et al.•Epidemiology•2000

  Incluir item

• Stratification and weighting via the propensity score in estimation of causal treatment effects

  Open Access•Jared K Lunceford, Jared Lunceford et al.•Statistics in Medicine•2004

  Incluir item

• On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9

  Jerzy Splawa-Neyman, D M Dabrowska et al.•Statistical Science•1990

  Incluir item

• Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

  Paul R Rosenbaum, Donald B Rubin•Journal of the American…•1984

  Incluir item

• Estimation of Regression Coefficients When Some Regressors are not Always Observed

  James M Robins, Andrea Rotnitzky et al.•Journal of the American…•1994

  Incluir item

• Bayesian Inference for Causal Effects

  Donald B Rubin•The Annals of Statistics•1978

  Incluir item

• The central role of the propensity score in observational studies for causal effects

  Paul R Rosenbaum, Donald B Rubin•Biometrika•1983

  Incluir item

• Estimating causal effects of treatments in randomized and nonrandomized studies.

  Donald B Rubin•Journal of Educational Psychology•1974

  Incluir item